These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2208237)

  • 21. Diabetic neuropathy differs in type 1 and type 2 diabetes.
    Sima AA; Kamiya H
    Ann N Y Acad Sci; 2006 Nov; 1084():235-49. PubMed ID: 17151305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.
    Enck P; Rathmann W; Spiekermann M; Czerner D; Tschöpe D; Ziegler D; Strohmeyer G; Gries FA
    Z Gastroenterol; 1994 Nov; 32(11):637-41. PubMed ID: 7886972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of polyneuropathy on foot microcirculation in Type II diabetes.
    Nabuurs-Franssen MH; Houben AJ; Tooke JE; Schaper NC
    Diabetologia; 2002 Aug; 45(8):1164-71. PubMed ID: 12189447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity.
    Giannini C; Dyck PJ
    Ann Neurol; 1995 Apr; 37(4):498-504. PubMed ID: 7717686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sympathetic skin responses and variability of the R-R interval: correlation with the severity stages of diabetic polyneuropathy].
    Chassande B; Charpentier G; Budy I; Willer JC; Lille F
    Rev Neurol (Paris); 1996 Oct; 152(10):623-9. PubMed ID: 9033955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensorimotor and autonomous polyneuropathies in diabetic children and adolescents].
    Mayr N; Wimberger D; Mamoli B; Schober E
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1986 Sep; 17(3):133-9. PubMed ID: 3021430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Koç F; Uysal H; Sarica Y
    Diabetes Res Clin Pract; 2007 Oct; 78(1):56-9. PubMed ID: 17408800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of heart rate and arterial blood pressure regulation in diabetes mellitus. Relation with age, duration of diabetes and presence of peripheral neuropathy.
    Beylot M; Haro M; Orgiazzi J; Noel G
    Diabete Metab; 1983 Sep; 9(3):204-11. PubMed ID: 6653859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Italian General Practitioner Study Group (IGPSG).
    Beghi E; Monticelli ML
    Acta Neurol Scand; 1997 Oct; 96(4):223-8. PubMed ID: 9325473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to heat-shock protein 65 and neopterin levels in patients with type 1 diabetes mellitus.
    Weitgasser R; Lechleitner M; Koch T; Galvan G; Mühlmann J; Steiner K; Hoppichler F
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):127-31. PubMed ID: 12784185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus.
    Urban PP; Forst T; Lenfers M; Koehler J; Connemann BJ; Beyer J
    Electromyogr Clin Neurophysiol; 1999; 39(5):267-72. PubMed ID: 10421997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyneuropathy in type 1 and type 2 diabetes: do we need different examinations?
    Gdynia HJ; Ludolph AC
    Diabetes Metab Res Rev; 2010 Feb; 26(2):107-8. PubMed ID: 20355003
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of alpha-lipoic acid in diabetic polyneuropathy treatment.
    Bureković A; Terzić M; Alajbegović S; Vukojević Z; Hadzić N
    Bosn J Basic Med Sci; 2008 Nov; 8(4):341-5. PubMed ID: 19125705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life.
    Ovayolu N; Akarsu E; Madenci E; Torun S; Ucan O; Yilmaz M
    Int J Clin Pract; 2008 Jul; 62(7):1019-25. PubMed ID: 18410351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes Mellitus Type Has Impact on Cutaneous Silent Period.
    Drnda S; Suljic E
    Med Arch; 2019 Oct; 73(5):326-330. PubMed ID: 31819306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrophysiological diagnosis of diabetic polyneuropathy in patients with newly detected diabetes Type I].
    Macheret EL; Korzh NA
    Lik Sprava; 2001; (4):118-21. PubMed ID: 11692690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic peripheral polyneuropathy].
    Iuldashev ShG; Kaĭlakov AM
    Probl Endokrinol (Mosk); 1977; 23(4):23-6. PubMed ID: 198765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology, neurological examinations and diagnosis of diabetic polyneuropathy].
    Sasaki H
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():445-50. PubMed ID: 23156436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.